Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2023 - 01 - 05 tags : Fda save search
MediciNova to Meet with U.S. FDA to Discuss Clinical Development of a Parenteral Formulation of MN-166 (ibudilast)
Published: 2023-01-05 (Crawled : 00:00) - globenewswire.com
MNOV | $1.43 -5.92% -6.29% 40K
|
Health Technology
|
| O: 3.56%
H: 2.58%
C: 2.58%
mn-166 fda
FDA Grants Lantern Pharma Orphan Drug Designation for Drug Candidate LP-284 in Mantle Cell Lymphoma
Published: 2023-01-05 (Crawled : 15:20) - biospace.com/
LTRN | $6.0 0.0% 160K
|
Health Technology
|
| O: -7.58%
H: 4.01%
C: -4.71%
lp-284 fda designation pharma drug candidate grants
FDA Approves IND Submission Allowing ABVC BioPharma to Proceed With Clinical Study of ABV-1519 for Treatment of Non-Small Cell Lung Cancer
Published: 2023-01-05 (Crawled : 15:00) - biospace.com/
ABVC | News | $1.015 -9.38% -10.34% 1.8M
|
Wholesale Trade
|
| O: 106.45%
H: 46.09%
C: -16.41%
abv-1519 treatment fda biopharma lung cancer study submission
Vaxcyte’s VAX-24 Granted FDA Breakthrough Therapy Designation for the Prevention of Invasive Pneumococcal Disease in Adults
Published: 2023-01-05 (Crawled : 15:00) - biospace.com/
PPRUF | News | $359.318 37.56% 490
|
Consumer Non-Durables
|
| O: 1.3%
H: 2.07%
C: 1.45%
PPRUY | News | $36.19 -0.11% 360K
|
Manufacturing
|
| O: 0.44%
H: 0.55%
C: -0.17%
PCVX | $62.45 0.34% 0.34% 690K
|
Health Technology
|
| O: -0.13%
H: 0.45%
C: -1.58%
STRO M | $3.78 -4.06% -4.23% 720K
|
Health Technology
|
| O: -0.86%
H: 7.35%
C: 5.23%
vax-24 fda designation disease granted therapy pneumococcal
AUM Biosciences Receives U.S. FDA Rare Pediatric Disease … – Yahoo Finance
Published: 2023-01-05 (Crawled : 14:00) - spacfeed.com
ROSE | $11.66 0.0% 3.4K
|
Miscellaneous
|
| O: -0.48%
H: 9.15%
C: 3.08%
LTUM | $0.0347 33.16% 180K
|
Mining, Quarrying, and Oil and ...
|
| O: 0.0%
H: 0.21%
C: -4.76%
fda rare disease
AUM Biosciences Receives U.S. FDA Rare Pediatric Disease Designation for AUM302 for Treatment of Neuroblastoma – Yahoo Finance
Published: 2023-01-05 (Crawled : 13:20) - spacfeed.com
LTUM | $0.0347 33.16% 180K
|
Mining, Quarrying, and Oil and ...
|
| O: 0.0%
H: 0.21%
C: -4.76%
aum302 treatment fda rare designation disease
Orchard Therapeutics Announces U.S. FDA Clearance of IND Application for OTL-203 in MPS-IH
Published: 2023-01-05 (Crawled : 12:20) - globenewswire.com
ORTX | $16.7 0.0% 370K
|
Health Technology
|
| O: 33.65%
H: 4.61%
C: -8.47%
otl-203 fda clearance application therapeutics mps-ih mps-i
Press Release: FDA accepts nirsevimab application as first protective option against RSV disease for all infants
Published: 2023-01-05 (Crawled : 08:00) - globenewswire.com
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: -3.07%
H: 0.0%
C: 0.0%
fda disease rsv application
Gainers vs Losers
| 56% | 44% |
Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M
|
Health Technology
SINT | $0.0365 59.39% 37.26% 470M
|
Health Technology
WISA 4 | $9.19 50.66% 33.7% 65M
|
Electronic Technology
EDBL | News | $6.73 47.91% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 640K
|
Manufacturing
TCON | $2.33 36.26% 26.61% 2M
|
Health Technology
TIRX | $0.48 6.43% 24.58% 4.8M
|
KZIA | $0.38 30.58% 23.42% 300K
|
Health Technology
VNDA | News | $5.23 29.14% 22.56% 24M
|
Health Technology
ATNF | $1.91 29.05% 22.51% 310K
|
Your saved searches
Save your searches and get alerts when important news are released.